Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 112OTHER_GOV 4NIH 2NETWORK 2FED 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vitamin D Deficiency 1Polycystic Ovary Syndrome 1Insulin Resistance 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cholecalciferol × Clear all
NCT02328404 2016-08-04

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

Hayat Pharmaceutical Co. PLC

Phase 3 Completed
60 enrolled 37 charts

Insulin Resistance, Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡